Research Site

Otopeni 075100

2 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Carcinoma, Non-Small Cell Lung

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now